Literature DB >> 9051764

A subclass of GABAA/benzodiazepine receptor exclusively localized in the limbic system.

H Onoe1, H Tsukada, S Nishiyama, S Nakanishi, O Inoue, B Långström, Y Watanabe.   

Abstract

An in vivo saturation study using 11C-labelled Ro15-4513 with high specific radioactivity (> 70 GBq mumol-1) revealed the presence of very high-affinity and high-affinity binding sites (Kd values in the amygdala approximately 0.4 and 18.7 nM, respectively) in the gamma-aminobutyric acid type A/benzodiazepine (GABAA/BZ) receptor in the living monkey brain. Subtraction of an image obtained using [11C]Ro15-4513 with low specific radioactivity from an image obtained by that with high specific radioactivity, both of which were scanned with a high spatial resolution positron emission tomography camera, demonstrated that the very high-affinity sites are exclusively localized in the limbic system, such as in the amygdala, hippocampus, anterior cingulate, septum, nucleus accumbens and insular cortex. The localization of the very high-affinity binding sites, which may be derived from a subclass of central GABAA/BZ receptors, might account for the anxiolytic effect of BZ analogues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9051764     DOI: 10.1097/00001756-199612200-00024

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  5 in total

1.  Differential effects of lorazepam on sleep and activity in C57BL/6J and BALB/cJ strain mice.

Authors:  Xiangdong Tang; Linghui Yang; Nancy F Fishback; Larry D Sanford
Journal:  J Sleep Res       Date:  2009-09       Impact factor: 3.981

2.  Selective labelling of diazepam-insensitive GABAA receptors in vivo using [3H]Ro 15-4513.

Authors:  Luanda J Pym; Susan M Cook; Thomas Rosahl; Ruth M McKernan; John R Atack
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

3.  The role of fear and anxiety in the familial risk for major depression: a three-generation study.

Authors:  V Warner; P Wickramaratne; M M Weissman
Journal:  Psychol Med       Date:  2008-02-14       Impact factor: 7.723

4.  Mouse strain differences in the effects of corticotropin releasing hormone (CRH) on sleep and wakefulness.

Authors:  L D Sanford; L Yang; L L Wellman; E Dong; X Tang
Journal:  Brain Res       Date:  2007-11-12       Impact factor: 3.252

5.  Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images.

Authors:  James F M Myers; Lula Rosso; Ben J Watson; Sue J Wilson; Nicola J Kalk; Nicoletta Clementi; David J Brooks; David J Nutt; Federico E Turkheimer; Anne R Lingford-Hughes
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-04       Impact factor: 6.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.